JP2007512387A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512387A5
JP2007512387A5 JP2006542002A JP2006542002A JP2007512387A5 JP 2007512387 A5 JP2007512387 A5 JP 2007512387A5 JP 2006542002 A JP2006542002 A JP 2006542002A JP 2006542002 A JP2006542002 A JP 2006542002A JP 2007512387 A5 JP2007512387 A5 JP 2007512387A5
Authority
JP
Japan
Prior art keywords
carbon atoms
caprolactam
amino
pharmaceutically acceptable
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006542002A
Other languages
English (en)
Japanese (ja)
Other versions
JP5248779B2 (ja
JP2007512387A (ja
Filing date
Publication date
Priority claimed from GB0327775A external-priority patent/GB0327775D0/en
Priority claimed from GB0417436A external-priority patent/GB0417436D0/en
Priority claimed from GB0417734A external-priority patent/GB0417734D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/005030 external-priority patent/WO2005053702A2/en
Publication of JP2007512387A publication Critical patent/JP2007512387A/ja
Publication of JP2007512387A5 publication Critical patent/JP2007512387A5/ja
Application granted granted Critical
Publication of JP5248779B2 publication Critical patent/JP5248779B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006542002A 2003-12-01 2004-11-30 抗炎症剤 Expired - Lifetime JP5248779B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0327775.3 2003-12-01
GB0327775A GB0327775D0 (en) 2003-12-01 2003-12-01 Anti-inflammatory agents
GB0417436A GB0417436D0 (en) 2004-08-05 2004-08-05 Anti-inflammatory agents
GB0417436.3 2004-08-05
GB0417734A GB0417734D0 (en) 2004-08-10 2004-08-10 Anti-Inflammatory agents
GB0417734.1 2004-08-10
PCT/GB2004/005030 WO2005053702A2 (en) 2003-12-01 2004-11-30 Anti-inflammatory agents

Publications (3)

Publication Number Publication Date
JP2007512387A JP2007512387A (ja) 2007-05-17
JP2007512387A5 true JP2007512387A5 (https=) 2008-03-21
JP5248779B2 JP5248779B2 (ja) 2013-07-31

Family

ID=34657584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006542002A Expired - Lifetime JP5248779B2 (ja) 2003-12-01 2004-11-30 抗炎症剤

Country Status (16)

Country Link
US (1) US20080227724A1 (https=)
EP (2) EP2279741A3 (https=)
JP (1) JP5248779B2 (https=)
KR (1) KR101228268B1 (https=)
CN (1) CN103393691A (https=)
AR (1) AR047730A1 (https=)
CA (1) CA2547651C (https=)
CY (1) CY1113171T1 (https=)
DK (1) DK1691814T3 (https=)
ES (1) ES2390272T3 (https=)
IL (1) IL175857A0 (https=)
PL (1) PL1691814T3 (https=)
PT (1) PT1691814E (https=)
SI (1) SI1691814T1 (https=)
TW (1) TWI356821B (https=)
WO (1) WO2005053702A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418426A (en) 2004-08-18 2006-03-29 Univ Cambridge Tech Alpha-(acylamino)-bicyclolactam derivatives for treatment of inflammatory disorders
AU2011226837B2 (en) * 2004-09-02 2014-09-18 Cambridge Enterprise Limited Ligands for G-protein coupled receptors
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2455539B (en) * 2007-12-12 2012-01-18 Cambridge Entpr Ltd Anti-inflammatory compositions and combinations
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent
US9340483B2 (en) * 2012-02-15 2016-05-17 Anida Pharma Inc. Methods of treating amyotrophic lateral sclerosis
JP7689356B2 (ja) * 2017-01-18 2025-06-06 ウニヴェルジテート オートノマ デ バルセロナ 神経変性疾患及び/又は自己免疫性疾患の処置において使用するための抗炎症性脂質メディエーター

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB327775A (en) 1929-01-21 1930-04-17 John Harry Grayson Improvements in thermostats
NL37108C (https=) 1933-06-02
US3697562A (en) * 1969-10-17 1972-10-10 Allied Chem Novel fluorocarbon diamides
JPS53121781A (en) * 1977-03-30 1978-10-24 Torii Yakuhin Kk Caprolactum derivatives
JPS625994A (ja) * 1985-07-02 1987-01-12 Toray Ind Inc リジン誘導体の製造法
EP0312157A3 (en) * 1987-10-13 1990-07-25 Merck & Co. Inc. Tetrapeptide renin inhibitors having a novel c-terminal amino acid
JP3054738B2 (ja) * 1988-07-22 2000-06-19 武田薬品工業株式会社 チアゾロ[5,4―b]アゼピン誘導体
DK316989D0 (da) 1989-06-26 1989-06-26 Novo Nordisk As Enzymer
US5430022A (en) * 1990-05-14 1995-07-04 Fujisawa Pharmaceutical Co., Ltd. Peptide compound and its preparation
IT1247698B (it) * 1990-06-21 1994-12-30 Sigma Tau Ind Farmaceuti 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1254471B (it) * 1992-02-27 1995-09-25 Magis Farmaceutici Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
US5821231A (en) * 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
EA002348B1 (ru) * 1995-02-22 2002-04-25 Новартис Аг Соединения 1-арил-2-ациламиноэтана и их применение в качестве антагонистов нейрокинина, в частности нейрокинина 1
SG64939A1 (en) * 1995-07-17 2002-02-19 Mitsui Chemicals Inc Olefin polymerization catalyst, process for preparing olefin polymer, and olefin polymer
JP3633060B2 (ja) 1995-09-22 2005-03-30 Jsr株式会社 低結晶性エチレン系ランダム共重合体およびその組成物
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
EP0910564B1 (en) * 1995-11-28 2007-10-31 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
EA002100B1 (ru) * 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6506782B1 (en) * 1998-02-27 2003-01-14 Athena Neurosciences, Inc. Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ES2255251T3 (es) * 1998-03-20 2006-06-16 Daiichi Asubio Pharma Co., Ltd. Inhibidores de nf-kb que contienen derivados de benzoquinona.
US6395282B1 (en) 1998-04-16 2002-05-28 University Of Rochester Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
HRP990246A2 (en) * 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
EP2386565A3 (en) 1999-01-12 2013-11-20 Cambridge Enterprise Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6344450B1 (en) * 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
WO2001068655A2 (en) * 2000-03-10 2001-09-20 Ariad Pharmaceuticals, Inc. Caprolactam derivatives and uses thereof

Similar Documents

Publication Publication Date Title
US7217701B2 (en) Intracellular calcium concentration increase inhibitors
EP2592066B1 (en) Aminocarboxylic acid derivative and medical use thereof
JP2007502264A5 (https=)
RU2439054C2 (ru) Соль алискирена и серной кислоты
JP2004516285A5 (https=)
JP2006508107A5 (https=)
HUE032113T2 (en) Methylphenidate-prodrugs, processes of making and using the same
JP2007512387A5 (https=)
JP2005500312A5 (https=)
RU2004137279A (ru) Производные дифенилазетидинона для лечения нарушений метаболизма липидов
JP2008509187A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2005507923A (ja) Ccr1受容体アンタゴニスト活性を有するピペラジン誘導体
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
PT2420491E (pt) Compostos de piperidina 3,5-substituída como inibidores de renina
TWI534125B (zh) Novel compounds, salts thereof or solvates thereof, and pharmaceutical compositions and pharmaceutical products containing the same
JP2016537353A (ja) 脂肪酸ナイアシン複合体
JP2008509210A5 (https=)
JP2007509052A5 (https=)
JP2020510071A (ja) 特発性肺線維症の治療
JP2008542386A5 (https=)
JP2008543821A5 (https=)
EP1174131A1 (en) Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
RU2006123438A (ru) Противовоспалительные средства
CN1612855A (zh) 逆转和预防心血管疾病的方法